Patent Application
20200164342
The present disclosure is generally related to metal organic frameworks and methods of making and using the same. More particularly, the present disclosure is generally related to lithiated cyclodextrin metal organic frameworks and method of making and using the same.
The advent of a renewable, edible and porous framework[1]—namely, cyclodextrin-metal organic frameworks (CD-MOFs) derived from γ-cyclodextrin[2] (γ-CD) and alkali metal salts—constitutes a class of porous frameworks that can be synthesized from completely nontoxic, naturally occurring starting materials on a large scale.[3] Since the serendipitous discovery[3a] of CD-MOFs in 2010 and as a result of their ease of synthesis and the ready availability of their building blocks, they have found applications in gas sorption,[3b, 4] sensors,[5] drug delivery,[6] encapsulation of volatile compounds and fullerenes[7] in addition to hydrocarbon separations.[3e, 8]
One of the unique features of metal-organic frameworks (MOFs) is the flexibility in their design and syntheses.[9] Postsynthetic modifications of MOFs, leading to the introduction of other metals into their secondary building units (SBUs) have been achieved,[10] while retaining their porous frameworks and the structural integrities. Furthermore, the organic linkers/struts in MOFs can also be exchanged[11] through the use of ingenious postsynthetic techniques to install targeted functionalities. The incorporation of different metal ions into the frameworks of MOFs, in order to form mixed-metal organic frameworks, has become relevant in recent years in relation to attempts to explore applications in various fields, e.g., heterogeneous catalysis,[11b] charge carriers,[12] gas uptake,[10b, 13] and photocatalytic activity.[10d]
Although several alkali metal salts have been employed in the generation of CD-MOFs, there are only three porous frameworks[3b, 3c]—CD-MOF-1, CD-MOF-2, and CD-MOF-3—obtained from γ-CD and the alkali metal cations K+, Rb+, and Cs+, respectively. The challenge in preparing CD-MOFs with cations, other than these three alkali metal ions, lies in an inability to obtain crystalline highly porous frameworks.[3d, 14] It transpires that the various alkali metals salts—e.g., KOH, RbOH, CsOH, Na2CO3, K2CO3, KF, KCl, KBr, NaBPh4—form[3c] cubic crystals with γ-CD, occupying the space group 1432. Among them all, only CD-MOFs-1-3, synthesized from KOH, RbOH and CsOH, respectively, have been characterized[3] by full crystal structural analyses.
Disclosed herein are cyclodextrin metal organic frameworks (CD-MOFs) and methods of making and using the same. The CD-MOFs are prepared from a co-crystallization methodology using at least two different cations. The metal organic framework comprises a coordinated network of repeating units extending in three dimensions, wherein the repeating unit comprises a cyclodextrin and a metal salt component. The metal salt component comprises a first coordinating metal cation and a second coordinating metal cation and the first coordinating metal cation and the second coordinating metal cation are different. Suitably, the cyclodextrin is γ-cyclodextrin.
The first coordinating metal cation and the second coordinating metal cation may Group I metal cations. The first coordinating metal cation is Li+. The second coordinating metal cation may be K+. Suitably, the metal salt component comprises both Li+ and K+.
The metal organic framework may have one or more of the following properties: a Brunauer-Emmett-Teller (BET) surface area of at least 600 m2 g-1; a CO2 absorption capacity of at least 2.0 mmol g-1 at 298 K and 1 bar; a CO2 absorption capacity of at least 3.0 mmol g-1 at 273 K and 1 bar; a H2 absorption capacity of at least 80 cm3 g-1 at 77 K and 1 bar; or a pore maxima centered between about 8.0 Å and about 20.0 Å. Suitably the metal organic framework has at least two of these properties. In some embodiments, the metal organic framework has all of these properties.
The metal organic framework may have any suitable molar ratio of the first coordinating metal cation to the second coordinating metal cation that allows for the preparation of a porous network. Suitably, the molar ratio of the first coordinating metal cation to the second coordinating metal cation is between about 1:99 to about 35:65. In some cases, the molar ratio of the first coordinating metal cation to the second coordinating metal cation is between about 20:85 to about 35:65.
The repeating unit may comprise twisted (CD)6 repeating cubes. The first coordinating metal cation and the second coordinating metal cation may be coordinated to six of the eight α-D-glucopyranosyl residues in an alternating 1°/2° face fashion and/or the framework may also comprise spherical cavities.
The metal organic framework may be capable of absorbing gases and the metal organic framework may further comprise an absorbed gas. Exemplary absorbed gasses comprise CO2, H2, or N2.
The metal organic frameworks may be capable of forming crystalline compositions. The compositions may have a molecular packing arrangement belonging to the R 3 2 space group. In some embodiments, the metal organic framework has lattice parameters of a=43.1±1.0 Å, b=43.1±1.0 Å, c=28.0±1.0 Å, α=90°, β=90°, and γ=120°.
A method of preparing the metal organic frameworks is also provided. The method comprise providing a solution comprising a cyclodextrin, a metal salt component, and a first solvent and adding a second solvent to the solution to prepare the metal organic framework, wherein the metal salt component comprises a first coordinating metal cation and a second coordinating metal cation and wherein the cyclodextrin, the first coordinating metal cation, or the second coordinating metal cation have a lower solubility in the second solvent than the first solvent. The first and second coordinating metal cations may be any of the cations described above. The molar ratio of the first coordinating metal cation and the second coordinating metal cation to cyclodextrin maybe greater than about 8.0 and/or the molar ratio of the first coordinating metal cation to the second coordinating metal cation may be between about 15:1 to about 1:15. The cyclodextrin may be a γ-cyclodextrin.
A method of use the metal organic frameworks for the absorption of a gas is also provide. The method comprises providing a metal organic framework and a gas to be adsorbed under conditions sufficient for the adsorption of the gas within the metal organic framework.
Exemplary gasses to be absorbed include without limitation CO2, H2, or N2.
Non-limiting embodiments of the present invention will be described by way of example with reference to the accompanying figures, which are schematic and are not intended to be drawn to scale. In the figures, each identical or nearly identical component illustrated is typically represented by a single numeral. For purposes of clarity, not every component is labeled in every figure, nor is every component of each embodiment of the invention shown where illustration is not necessary to allow those of ordinary skill in the art to understand the invention.
Disclosed herein are cyclodextrin metal organic frameworks (CD-MOFs) and methods of making and using the same. The CD-MOFs are prepared from a co-crystallization methodology using at least two different cations. This methodology tackles the long-standing constraints of generating porous architectures from only a select few cations and allows for the preparation of new materials having high surface areas and high absorption capacities.
Metal-organic frameworks (MOFs) are a class of hybrid materials comprising inorganic nodes and organic linkers. More specifically, the MOFs have a structure comprising inorganic (e.g., metal) nodes, also referred to as centers, coordinated via organic molecular linkers to form a highly connected porous network. The CD-MOFs are porous materials constructed from CD-based organic molecular linker coordinated by metal cation nodes. CD is composed of a circular oligomer of five or more α-D-glucopyranosyl residues
linked 1→4. Suitably, the number of residues n may be greater than or equal to 5 and less than or equal to 15. This includes α-CD, β-CD, and γ-CD, which are 6-, 7- and 8-membered rings, respectively. The constrained, circular oligomers form tori. The tori have a macrocyclic character that is composed of a central lipophilic cavity and hydrophilic outer surface. The tori also have a truncated cone or “bucket” shape having a primary (1°) face comprising the C-6 hydroxyl moieties and a secondary (2°) face comprising the C-2 and C-3 hydroxyl moieties. The CD-MOFs built from the CD tori are generally characterized by larger cavities connected be a series of smaller channel-like pores. Charge-balancing counter ions are present in the CD-MOF structures to compensate for the metal cation nodes. The charge balancing anions that are initially present in the CD-MOFs are derived from the salts used to synthesize the CD-MOFs. For example, if the CD-MOFs are crystallized from a metal hydroxide, the charge-balancing anions will be hydroxy (OH−) anions.
CD-MOFs are highly water soluble, non-toxic, and can be constructed from biocompatible CD and biocompatible metals. Additionally, CD-MOFs are readily degraded. For example, γ-CD can be hydrolyzed in the presence of α-amylase, whereas α- and β-CD are digestible by intestinal microflora and other microorganisms.
As used herein “cyclodextrin” or “CD” is meant to include circular oligomers of α-D-glucopyranosyl residues and derivatives prepared by the chemical modification of the hydroxyl moieties on either or both of the primary or secondary faces. The chemical modification of the hydroxyl moieties are suitably accomplished prior to assembly of the CD-MOF or post-assembly of the CD-MOF. Accordingly, the CD-MOFs may comprise a CD compound of Formula I
wherein n=0-10; and R is independently selected from the group consisting of —OH; —NR′R″; C1-C18 alkyl optionally substituted with one, two, three, four or five R1 groups; C2-C18 alkenyl optionally substituted with one, two, three, four or five R1 groups; C2-C18 alkynyl optionally substituted with one, two, three, four or five R1 groups; C1-C18 alkoxy optionally substituted with one, two, three, four or five R1 groups; —S(═O)2R′; —S(═O)OR′; —S(═O)R′; —C(═O)OR′; —CN; —C(═O)R′; —SR′, —N═N+═N−; —NO2, —OSO2R1; —C(═O)OR′, —O(═S)SR′, —P(═O)(OR′)2; —OP(═O)(OR′)2; —P(═O)(OR′)R″; —N═R′R″; —NR′P(OR″)(OR′″); —OC(═O)NR′R″; aryl optionally substituted with one, two, three, four or five R2 groups; heteroaryl optionally substituted with one, two, three, four or five groups independently selected from R2 groups; and cycloalkyl optionally substituted with one, two, three, four or five groups independently selected from R2 groups; wherein each R1 group is independently selected from hydroxyl, halo, lower alkoxy, —NR′R″, —S(═O)2R′, —S(═O)OR′, —S(═O)R′, —C(═O)OR′, —CN, —C(═O)R′, —N═N+═N−, —SR′, —NO2, —OSO2R′, —C(═O)OR′, —O(═S)SR′, —P(═O)(OR′)2, —OP(═O)(OR′)2; —P(═O)(OR′)R″, —N═R′R″, —NR′P(OR″)(OR′″), —OC(═O)NR′R″, aryl optionally substituted with one, two, three, four or five R′ groups; heteroaryl optionally substituted with one, two, three, four or five groups independently selected from R′ groups; and cycloalkyl optionally substituted with one, two, three, four or five groups independently selected from R′ groups; wherein each R2 group is independently selected from lower alkyl, lower alkyenyl, lower alkynyl, hydroxyl, halo, lower alkoxy, —NR′R″, —S(═O)2R′, —S(═O)OR′, —S(═O)R′, —C(═O)OR′, —CN, —C(═O)R′, —N═N+═N−, —SR′, —NO2, —OSO2R1, —C(═O)OR′, —O(═S)SR′, —P(═O)(OR′)2, —OP(═O)(OR′)2; —P(═O)(OR′)R″; —N═R′R″; —NR′P(OR″)(OR′″); —OC(═O)NR′R″, aryl optionally substituted with one, two, three, four or five R′ groups; heteroaryl optionally substituted with one, two, three, four or five groups independently selected from R′ groups; and cycloalkyl optionally substituted with one, two, three, four or five groups independently selected from R′ groups; and wherein each R′ and R″ are independently selected from the group consisting of H, lower alkyl and aryl (U.S. Patent Publication No. 2012/0070904).
α-CD, β-CD, and γ-CD in the present invention are meant as a 6-, 7- and 8-membered ring, respectively. In certain embodiments, the R group of α-CD, β-CD, or γ-CD comprises —OH. In other embodiments, the R group of α-CD, β-CD, or γ-CD comprises any of the other groups described above.
“Lower alkyl” in the present invention is meant as a straight or branched chain alkyl radical having, 1-6, and preferably from 1-3, carbon atoms. Examples include but are not limited to methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, tert-butyl, pentyl, 2-pentyl, isopentyl, neopentyl, hexyl, 2-hexyl, 3-hexyl, and 3-methylpentyl. Each alkyl group may be optionally substituted with one, two or three substituents such as, for example, a halo, cycloalkyl, aryl, alkenyl or alkoxy group and the like.
“Lower alkenyl” is meant as a straight or branched hydrocarbon radical having from 2 to 6 atoms and one or two double bonds and includes, for example, ethenyl, propenyl, 1-but-3-enyl, 1-pent-3-enyl, 1-hex-5-enyl. The alkenyl group can also be optionally mono-, di-, or trisubstituted with, for example, halo, aryl, cycloalkyl or alkoxy and the like.
“Lower alkynyl” is meant as a straight or branched hydrocarbon radical having from 2 to 6 atoms and one or two triple bonds and includes, for example, propynyl, 1-but-3-ynyl and the like. The alkynyl group can also be optionally mono-, di-, or trisubstituted with, for example, halo, aryl, cycloalkyl or alkoxy and the like.
“Lower alkoxy” is meant as an —O— lower alkyl group wherein lower alkyl is as defined above.
“Halo” or “halogen” is meant as a halogen radical of fluorine, chlorine, bromine or iodine.
“Aryl” is meant as an aromatic carbocylic radical having a single ring (e.g. phenyl), multiple rings (e.g. biphenyl) or multiple fused rings in which at least one is aromatic (e.g. 1,2,3,4-tetrahydronaphthyl).
“Heteroaryl” is meant as one or multiple fused aromatic ring systems of 5-, 6- or 7-membered rings containing at least one and up to four heteroatoms selected from nitrogen, oxygen or sulfur. Examples include but are not limited to furanyl, thienyl, pyridinyl, pyrimidinyl, benzimidazolyl and benzoxazolyl.
“Cycloalkyl” is meant as a carbocylic radical having a single ring (e.g. cyclohexyl), multiple rings (e.g. bicyclohexyl) or multiple fused rings (e.g.). In addition, the cycloalkyl group may have one or more double bonds.
The CD-MOFs comprise a metal salt component. The metal salt component comprises at least two different coordinating metal cations. The coordinating metal cations act as nodes or centers to coordinate the organic CD linkers to form highly connected porous networks. The metal cations may be suitably selected from metal cations capable of forming complexes with carbohydrates. The metal cations may be independently selected from 1+, 2+, or 3+ cations. Suitably, at least two of the different metal cations may each have the same oxidation state but they need not be. The metal cations may be independently selected from Group I (Alkali) metal cations, Group II (Alkaline earth) metal cations, transition metal cations, lanthanoid metal cations, or post-transitional metal cations. Suitably, at least two of the different metal cations are each Group I, Group II, transition, post-transitional metal cations. Examples of metal cations include, without limitation, Li+, Na+, K+, Rb+, Cs+, Mg2+, Ca2+, Sr2+, Ba2+, Ag+, Cd2+, La3+, Yb+, Sn2+, Pb2+. In some embodiments, the at least one of the metal cations is selected from Group I transition metals, suitably Li+, Na+, K+, Rb+, or Cs+. In other embodiments, at least two of the metal cations are selected from Group I transition metals, suitably a combination of Li+, Na+, K+, Rb+, or Cs+. Examples include, without limitation, Li+ and Na+, Li+ and K+, Li+ and Rb+, Li+ and Cs+, Na+ and K+, Na+ and Rb+, Na+ and Cs+, K+ and Rb+, K+ and Cs+, or Rb+ and Cs+.
The molar ratio of the first coordinating metal cation to the second coordinating metal cation in the CD-MOF may be any molar ratio that allows for the formation of a highly connected porous network of organic CD linkers coordinated with the first and second coordinated metal cations. The ratio of the first and second coordinate metal cation may be varied between about 1:99 and about 99:1, about 20:80 and about 80:20, or about 35:65 and about 65:35. In some embodiments, the ratio of the first and second coordinate metal cation may be varied between about 1:99 and about 35:65 or about 20:80 and 35:65.
Suitably, the porous network comprises interconnected pores and channels having a high surface area. Suitably, the CD-MOF has a Brunauer-Emmett-Teller (BET) surface area of at least 600 m2 g−1, at least 800 m2 g−1, at least 1000 m2 g−1, or at least 1200 m2 g−1. In some embodiments, the BET surface area is between about 800 m2 g−1 and about 1500 m2 g−1, about 1000 m2 g−1 and about 1400 m2 g−1, or about 1200 m2 g−1 and about 1300 m2 g−1. Suitably the CD-MOF has a pore maxima centered between about 8.0 Å and about 20.0 Å, or about 10.0 Å and about 18.0 Å, or about 11.0 Å and about 13.0 Å. In some embodiments, the pore may be a spherical cavity prepared from a repeating unit of (CD)6 cubes. Suitably the CD-MOF has a CO2 absorption capacity of at least 2.0 mmol g−1, 2.5 mmol g−1, or 3.0 mmol g−1 at 298 K and 1 bar and/or a CO2 absorption capacity of at least 3.0 mmol g−1, 3.5 mmol g−1, 4.0 mmol g−1, or 4.0 mmol g−1 at 273 K and 1 bar. In some embodiments, the CD-MOF has a CO2 absorption capacity between about 2.0 mmol g−1 and about 5.0 mmol g−1, about 2.5 mmol g−1 and about 4.5 mmol g−1, or about 3.0 mmol g−1 and about 4.0 mmol g−1 at 298 K and 1 bar and/or a CO2 absorption capacity between about 3.0 mmol g−1 and about 6.0 mmol g−1, about 3.5 mmol g−1 and about 5.5 mmol g−1, or about 4.0 mmol g−1 and about 5.0 mmol g−1 at 273 K. Suitably the CD-MOF has a H2 absorption capacity of at least 80 cm3 g−1, 100 cm3 g−1, or 80 cm3 g−1 at 77 K and 1 bar. In some embodiments, the CD-MOF has a H2 absorption capacity between about 80 cm3 g−1 and about 180 cm3 g−1, about 100 cm3 g−1 and about 160 cm3 g−1, or about 120 cm3 g−1 and about 140 cm3 g−1 at 77K and 1 bar.
Crystalline compositions may be prepared from CD-MOFs described herein. The crystalline composition may have a packing arrangement categorized by a trigonal crystal system. Suitably, the crystalline composition may have a R 3 2 space group. Lattice parameters or unit cell parameters may be about a=43.1±1.0 Å, b=43.1±1.0 Å, c=28.0±1.0 Å, α=90°, β=90°, and γ=120°. In some embodiments, lattice parameters are about a=43.1±0.5 Å, b=43.1±0.5 Å, c=28.0±0.5 Å, α=90°, β=90°, and γ=120° or a=43.1±0.1 Å, b=43.1±0.1 Å, c=28.0±0.1 Å, α=90°, β=90°, and γ=120°.
Generally, CD-MOFs are prepared by dissolution of both the cyclodextrin component and the metal salt component in any solvent in which both have solubility. Isolation of CD-MOFs is done by addition of a second solvent in which either of the components has poor solubility, including, but not limited to, C1-C18 alcohols, acetone, tetrahydrofuran, dioxane, acetonitrile, as well as other common organic solvents miscible with water, or any mixtures thereof. As such, in a specific non-limiting embodiment of the invention, methanol is allowed to vapor diffuse into an aqueous solution containing γCD, KOH, and LiOH in various molar ratios described in Table 1.
The metal salt component to be dissolved into solution with the cyclodextrin may comprises two or more metal salts. The first of the salts comprises the first coordinating metal cation and the second of the salts comprises the second coordinating metal cation. The salts may be added in any appropriate molar or equivalent ratio that allows for the formation of the CD-MOF. Suitably, the first salt and second salt may be provided in a molar ratio to the cyclodextrin component of at least 6.0:1.0. In some embodiments, the first salt and second salt may be provided in a molar ratio to the cyclodextrin component of at least 7.0:1.0, at least 8.0:1.0, or at least 9.0:1.0. The molar ratio of the first salt and second salt may be provided to allow for the formation of the CD-MOF with the desired ratio of the first coordinating metal cation and the second coordinating metal cation into the MOF. Suitably, the molar ratio of the first salt to the second salt may be about 15.0:1.0 to about 1.0:15.0. In some embodiments, the molar ratio of the first salt to the second salt may be about 7.0:1.0, about 3.0:1.0, about 5.0:3.0, about 1.0:1.0, or any interval therebetween.
The metal salt component also comprises a counter anion. The anion may be suitably selected from inorganic and organic anions. Exemplary inorganic anions include, without limitation, chloride, fluoride, hydroxide, sulfide, sulfinate, carbonate, chromanate, cyanide, and the like. Exemplary, organic anions include, without limitation, benzoate, azobenzene-4,4′-dicarboxylate, acetate, oxalate, and the like. The metal salt component may comprise one or more anions depending on the choice of salts selected for dissolution. For example, the metal salt component may comprise hydroxide anions from the dissolution of LiOH and KOH salts as demonstrated in the Examples, but the metal salt component may also comprise two different anions such as hydroxide and chloride from the dissolution of LiOH and KCl salts. The CD-MOF may comprise an associated counter anion before or after the CD-MOF is isolated from preparation.
As demonstrated in the Examples that follow, co-crystallization of K+ and Li+ ions with γ-cyclodextrin (γ-CD) has been shown to substitute the K+ ion sites partially by Li+ ions, while retaining the structural integrity and accessible porosity of CD-MOF-1. A series of experiments, resulting from varying the K+/Li+ ratio with respect to that of γ-CD, have been conducted in order to achieve the highest possible proportion of Li+ ions in the framework. Attempts to obtain a CD-MOF containing only Li+ ions resulted in non-porous materials. The structural occupancy on the part of the Li+ ions in the new CD-MOF has been confirmed by single crystal X-ray analysis by determining the vacancies of K+ sites and accounting for the cation/γ-CD ratio in CD-MOF-1. The proportion of Li+ ions has also been confirmed by elemental analysis, while powder X-ray diffraction has established the stability of the extended framework. This noninvasive synthetic provides a new approach to generating mixed-metal CD-MOFs for obtaining porous framework unattainable de novo. Furthermore, the CO2 and H2 capture capacities of the Li+-substituted CD-MOF have been shown to exceed the highest sorption capacities reported so far for CD-MOFs.
Herein, we demonstrate a synthetic methodology which overcomes the limitation of preparing porous CD-MOFs with Li+ ions by co-crystallizing a metal salt component comprises two different alkali metal salts, KOH and LiOH, with γ-CD. This follows all of our failed attempts to crystallize γ-CD with LiOH alone to afford the prototypical porous structure of a CD-MOF. In the light of this failure, we turned our attention to the development of a methodology that relies on the co-crystallization of LiOH and KOH with γ-CD to produce partially Li+ ion-substituted CD-MOF (referred to as “Li/K-CD-MOF”) by replacing some of the K+ sites in CD-MOF-1 with Li+ ions.
The synthetic protocol for CD-MOF-1, i.e., CD-MOF-1 is synthesized by MeOH vapor diffusion into an aqueous solution of 8.0 equiv of KOH and 1.0 equiv of γ-CD during 7 days to afford a crop of colorless, cubic, single crystals in about 60% yield was adopted.[3a-3c] Li/K-CD-MOF was prepared by combining 8.0 equiv of KOH and LiOH, with molar ratios of LiOH/KOH varied from Li0.2:K1.4 to Li1.4:K0.2, and 1.0 equiv of γ-CD in aqueous solution. Table 1. Vapor diffusion of MeOH into these solutions during 15 days resulted in cubic, colorless single crystals, suitable for X-ray crystallography, in 43-50% yield.
The proportions of Li+ ions occupying K+ sites in Li/K-CD-MOFs were confirmed by Inductively Coupled Plasma Optical Emission Spectroscopy (ICP-OES). The Li/K-CD-MOF crystals were washed well with MeOH in order to remove any unreacted LiOH from the crystals before ICP-OES analysis. Li/K-CD-MOFs were digested in 5% aqueous HNO3 solution. ICP-OES analyses confirmed that the proportions of Li+ ions in the mixed-metal CD-MOF increased on upping the amounts of LiOH employed in the co-crystallization of Li/K-CD-MOFs. Table 2. The highest K+/Li+ ratio, namely, K1.18Li0.61, we were able to obtain in Li/K-CD-MOFs was achieved from the co-crystallization of LiOH and KOH in a ratio of 1.4:0.2 with respect to 1 mol equiv γ-CD.
Single crystal X-ray analysis was performed on the sample of Li/K-CD-MOF containing the highest proportion of Li+ ions as indicated by ICP-OES. In contrast to CD-MOF-1, which is composed[3a] of γ-CD tori held together by K+ ions in a cubic unit cell of space group 1432, the solid-state structure (
K+ sites substitution by Li+ ions were located based on the absence of K+ ions in the framework. Since K+ ions are the heaviest atoms in the structure, the electron density and proportion of K+ ions can be determined with accuracy. The site occupancy of the K+ ions in the crystal structure was refined and the missing K+ ions were substituted with Li+ ions. This type of substitution is possible because (i) the chemistry and coordination sphere of the two alkali metal ions is similar, although the bond distances are different[15], and so it is expected that the Li+ ions will share the same site as the K+ ions, and (ii) each of the alkali metal ion sites is fully occupied, meaning that there cannot be vacancies on the alkali ion sites. Full occupancy is assumed on the account of the cation/γ-CD ratio in CD-MOF-1, where the proportion of cations must balance the γ-CD. Therefore the occupancies of K+ and Li+ ions are complementary, and (iii) any disorder in the γ-CD molecules does not affect the overall proportion of the alkali ions since the number of γ-CD molecules is fixed.
Powder X-ray diffraction (PXRD) experiments performed on CD-MOF-1 and Li/K-CD-MOF confirm (
The permanent porosities of CD-MOF-1 and Li/K-CD-MOF were examined (
The use of the accessible porosity of Li/K-CD-MOF for gas sorption analyses has also been investigated by studying the CO2 and H2 gas adsorption isotherms and comparing them with those for CD-MOF-1. These experiments exhibit the integrity of the structural porosity associated with the partially Li+ ion-substituted Li/K-CD-MOF. The CO2 adsorption-desorption isotherms for CD-MOF-1 and Li/K-CD-MOF were carried out at 273 (
The initial steep rise, which is observed at very low CO2 pressures, regardless of the temperature,[16] is believed to be the result of a chemisorption process. H2 sorption isotherms of Li/K-CD-MOF were also carried out at 77 K up to 1 bar.
In summary, we have tackled the long-standing constraints of generating CD-MOFs, from other than K+, Rb+ and Cs+ ions, by preparing extended frameworks containing two different cations ions. The Li+ ions incorporated into the K+ sites of CD-MOF-1 can be accomplished by co-crystallization of Li+ and K+ ions with γ-CD without sacrificing the porous architecture of the CD-MOFs. The partial substitution of K+ sites by Li+ ions in the frameworks has been established by determining the vacancies associated with the K+ sites. Some of the K+ sites are occupied by Li+ ions, which share the same coordination geometry as K+ ions. The Li/K-CD-MOF with the highest Li+/K+ ratio is stable upon removal of solvent and has revealed surface areas of approximately 1205 m2 g−1 which is slightly higher than that of CD-MOF-1. Moreover, the CO2 capture capacity is not hindered by the occupying Li+ ions and show CO2 uptakes of 4.5 and 3.1 mmol g−1 at 273 and 298 K, respectively. This findings show that our inability of synthesize CD-MOFs with alkali metal ions other than K+, Rb+ and Cs+ can be addressed by employing a co-crystallization methodology.
All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g., “such as”) provided herein, is intended merely to better illuminate the invention and does not pose a limitation on the scope of the invention unless otherwise claimed. No language in the specification should be construed as indicating any non-claimed element as essential to the practice of the invention.
All references, including publications, patent applications, and patents, cited herein are hereby incorporated by reference to the same extent as if each reference were individually and specifically indicated to be incorporated by reference and were set forth in its entirety herein.
Preferred aspects of this invention are described herein, including the best mode known to the inventors for carrying out the invention. Variations of those preferred aspects may become apparent to those of ordinary skill in the art upon reading the foregoing description. The inventors expect a person having ordinary skill in the art to employ such variations as appropriate, and the inventors intend for the invention to be practiced otherwise than as specifically described herein. Accordingly, this invention includes all modifications and equivalents of the subject matter recited in the claims appended hereto as permitted by applicable law. Moreover, any combination of the above-described elements in all possible variations thereof is encompassed by the invention unless otherwise indicated herein or otherwise clearly contradicted by context.
Potassium hydroxide (KOH), lithium hydroxide monohydrate (LiOH*H2O), γ-cyclodextrin (γ-CD) and methanol (MeOH) were purchased from Sigma Aldrich. All chemicals were used as received without further purification. CD-MOF-1 was prepared according to the literature procedures (Forgan, R. S. et al. J. Am. Chem. Soc. 2012, 134, 406-417; Smaldone, R. A. et al. Angew. Chem. Int. Ed. 2010, 49, 8630-8634).
CD-MOF-1: The synthetic protocol for CD-MOF-1 was adopted from the reported procedure. γ-CD (260 mg, 0.2 mmol) and KOH (89.7 mg, 1.6 mmol) were dissolved in H2O (4 mL). The solution was filtered through a 0.45-μm syringe filter and decanted into separate vials. MeOH (5 mL) was allowed to diffuse slowly into the solution over a period of a week. Colorless cubic crystals (216 mg, 61%), suitable for X-ray crystallographic analysis, were isolated, filtered and washed with MeOH (3×5 mL), before being left to dry at 60° C. in vacuum oven. Li/K-CD-MOF: γ-CD (260 mg, 0.2 mmol), KOH (11 mg, 0.2 mmol), LiOH.H2O (60 mg, 1.4 mmol) were dissolved in H2O (4 mL). The solution was filtered through a 0.45-μm syringe filter and decanted into separate vials. MeOH (5 mL) was allowed to diffuse slowly into the solution over a period of 15 days. Colorless cubic crystals (167 mg, 50%), suitable for X-ray crystallographic analysis, were isolated, filtered and washed with MeOH (3×5 mL), before being left to dry at 60° C. in vacuum oven. The samples with varying Li+:K+ ratio were also synthesized according to the same synthesis protocol (Table 1).
Powder X-ray diffraction patterns of CD-MOF-1 and Li/K-CD-MOF were collected on a Bruker AXS APEX2 diffractometer, equipped with a CCD detector and a CuKα IμS microfocus source with MX optics. Data were collected with an area detector as rotation frames over 180° in φ at 2θ values of 12 and 24° and exposed for 10 min for each frame. At a distance of 150 mm, the detector area covers 24° in 2θ. Overlapping sections of data were matched and the resulting pattern integrated using the Bruker APEX2 Phase ID program. Powder pattern data were treated for amorphous background scatter.
The proportion of Li+ and K+ ions were measured by Inductively Coupled Plasma Optical Emission Spectroscopy (ICP-OES) performed on a computer-controlled (QTEGRA software v. 2.2) Thermo iCap 7600 Duo ICP-OES (Thermo Fisher Scientific, Waltham, Mass., USA) operating in standard mode and equipped with a SPRINT valve and CETAC 520 autosampler (Teladyne CETAC, Omaha, Nebr., USA). The samples for ICP-OES were prepared by digesting crystals in aqueous nitric acid. Thermogravimetric analyses (TGA) were carried out at 10° C./min up to 800° C. under nitrogen flow (50 mL/min) using a SDTA851 (Mettler Toledo Instruments).
A suitable crystal of Li/K-CD-MOF mounted in inert oil and transferred to the cold gas stream of a Bruker APEX-II CCD diffractometer. The crystal was kept at 100.0 K during data collection. Using Olex2 (Dolomanov, O. V. et al. J. Appl. Cryst. 2009, 42, 339-341), the structure was solved with the ShelXS (Sheldrick, G. M. Acta Cryst. A 2008, 64, 112-122) structure solution program using Direct Methods and refined with the XL refinement package using Least Squares minimization. The solvent masking procedure as implemented in Olex2 was used to remove the electronic contribution of solvent molecules from the refinement. As the exact solvent content is not known, only the atoms used in the refinement model are reported in the formula.
aThe Li/K-CD-MOFs Crystals were washed with MeOH for 5-6 times to remove uncoordinated Li+ ions from the crystals before ICP-OES analysis. Li/K-CD-MOFs were digested in 5% aqueous HNO3 solution at room temperature over 3 hours.
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/US2018/043217 | 7/23/2018 | WO | 00 |
| Number | Date | Country | |
|---|---|---|---|
| 62535579 | Jul 2017 | US |
